Article

Innovative Approaches to the Diagnosis and Treatment of Glaucoma

New Orleans-There is always something new to learn in any medical specialty, and speakers at a Monday evening CME program at the New Orleans Marriott described innovative approaches to glaucoma diagnosis and treatment.

Robert N. Weinreb, MD, University of California, San Diego, program chair and moderator, led off the discussion of advances in glaucoma treatment, followed by a presentation on risk assessment given by Robert D. Fechtner, MD, New Jersey Medical School and University of Medicine and Dentistry of New Jersey, Newark.

David S. Friedman, MD, MPH, shared strategies for the crucial task of determining whether a patient is going blind from glaucoma and, if so, how to respond. Marlene R. Moster, MD, Thomas Jefferson Medical College and Wills Eye Hospital, Philadelphia, discussed ways of overcoming the hurdles of glaucoma management. George A. "Jack" Cioffi, Devers Eye Institute, Legacy Health System, Portland, OR, concluded the presentations with an evaluation of the role of glaucoma surgery.

The program was jointly sponsored by Ophthalmology Times and the New York Eye and Ear Infirmary and supported by an unrestricted educational grant from Alcon Laboratories Inc.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.